>
Switch to:

Forma Therapeutics Holdings EV-to-EBITDA

: -5.14 (As of Today)
View and export this data going back to 2020. Start your Free Trial

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Forma Therapeutics Holdings's enterprise value is $631.24 Mil. Forma Therapeutics Holdings's EBITDA for the trailing twelve months (TTM) ended in Dec. 2020 was $-122.87 Mil. Therefore, Forma Therapeutics Holdings's EV-to-EBITDA for today is -5.14.

NAS:FMTX' s EV-to-EBITDA Range Over the Past 10 Years
Min: -14.52   Med: -9.95   Max: 1.9
Current: -5.21

-14.52
1.9

During the past 3 years, the highest EV-to-EBITDA of Forma Therapeutics Holdings was 1.90. The lowest was -14.52. And the median was -9.95.

NAS:FMTX's EV-to-EBITDA is ranked lower than
99.99% of the 288 Companies
in the Biotechnology industry.

( Industry Median: 28.61 vs. NAS:FMTX: -5.21 )

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2021-05-05), Forma Therapeutics Holdings's stock price is $25.35. Forma Therapeutics Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2020 was $-4.83. Therefore, Forma Therapeutics Holdings's PE Ratio for today is .

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Forma Therapeutics Holdings EV-to-EBITDA Historical Data

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Forma Therapeutics Holdings Annual Data
Dec18 Dec19 Dec20
EV-to-EBITDA 0.00 0.00 -8.98

Forma Therapeutics Holdings Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20
EV-to-EBITDA Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 -14.03 -15.56 -8.98

Competitive Comparison
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap.


Forma Therapeutics Holdings EV-to-EBITDA Distribution

* The bar in red indicates where Forma Therapeutics Holdings's EV-to-EBITDA falls into.



Forma Therapeutics Holdings EV-to-EBITDA Calculation

Forma Therapeutics Holdings's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=631.236/-122.873
=-5.14

Forma Therapeutics Holdings's current Enterprise Value is $631.24 Mil.
Forma Therapeutics Holdings's EBITDA for the trailing twelve months (TTM) ended in Dec. 2020 was -31.6 (Mar. 2020 ) + -26.675 (Jun. 2020 ) + -31.991 (Sep. 2020 ) + -32.607 (Dec. 2020 ) = $-122.87 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Forma Therapeutics Holdings  (NAS:FMTX) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Forma Therapeutics Holdings's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=25.35/-4.83
=

Forma Therapeutics Holdings's share price for today is $25.35.
Forma Therapeutics Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2020 was 0.42 (Mar. 2020 ) + -4.58 (Jun. 2020 ) + -0.67 (Sep. 2020 ) + 0 (Dec. 2020 ) = $-4.83.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Forma Therapeutics Holdings EV-to-EBITDA Related Terms


Forma Therapeutics Holdings EV-to-EBITDA Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)